Triebel F - Search Results

1

LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.

Camisaschi C, Casati C, Rini F, Perego M, De Filippo A, Triebel F, Parmiani G, Belli F, Rivoltini L, Castelli C. Camisaschi C, et al. Among authors: triebel f. J Immunol. 2010 Jun 1;184(11):6545-51. doi: 10.4049/jimmunol.0903879. Epub 2010 Apr 26. J Immunol. 2010. PMID: 20421648

2

CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling.

Hannier S, Tournier M, Bismuth G, Triebel F. Hannier S, et al. Among authors: triebel f. J Immunol. 1998 Oct 15;161(8):4058-65. J Immunol. 1998. PMID: 9780176

3

Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells.

Avice MN, Sarfati M, Triebel F, Delespesse G, Demeure CE. Avice MN, et al. Among authors: triebel f. J Immunol. 1999 Mar 1;162(5):2748-53. J Immunol. 1999. PMID: 10072520

4

Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity.

Casati C, Camisaschi C, Rini F, Arienti F, Rivoltini L, Triebel F, Parmiani G, Castelli C. Casati C, et al. Among authors: triebel f. Cancer Res. 2006 Apr 15;66(8):4450-60. doi: 10.1158/0008-5472.CAN-05-2728. Cancer Res. 2006. PMID: 16618772

5

Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells.

Bayry J, Triebel F, Kaveri SV, Tough DF. Bayry J, et al. Among authors: triebel f. J Immunol. 2007 Apr 1;178(7):4184-93. doi: 10.4049/jimmunol.178.7.4184. J Immunol. 2007. PMID: 17371975

6

Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation.

Casati C, Camisaschi C, Novellino L, Mazzocchi A, Triebel F, Rivoltini L, Parmiani G, Castelli C. Casati C, et al. Among authors: triebel f. J Immunol. 2008 Mar 15;180(6):3782-8. doi: 10.4049/jimmunol.180.6.3782. J Immunol. 2008. PMID: 18322184

7

MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis.

Hemon P, Jean-Louis F, Ramgolam K, Brignone C, Viguier M, Bachelez H, Triebel F, Charron D, Aoudjit F, Al-Daccak R, Michel L. Hemon P, et al. Among authors: triebel f. J Immunol. 2011 May 1;186(9):5173-83. doi: 10.4049/jimmunol.1002050. Epub 2011 Mar 25. J Immunol. 2011. PMID: 21441454

8

Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.

Camisaschi C, De Filippo A, Beretta V, Vergani B, Villa A, Vergani E, Santinami M, Cabras AD, Arienti F, Triebel F, Rodolfo M, Rivoltini L, Castelli C. Camisaschi C, et al. Among authors: triebel f. J Invest Dermatol. 2014 Jul;134(7):1893-1902. doi: 10.1038/jid.2014.29. Epub 2014 Jan 17. J Invest Dermatol. 2014. PMID: 24441096 Free article.

9

Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity.

Castelli C, Triebel F, Rivoltini L, Camisaschi C. Castelli C, et al. Among authors: triebel f. Oncoimmunology. 2014 Dec 21;3(11):e967146. doi: 10.4161/21624011.2014.967146. eCollection 2014 Nov. Oncoimmunology. 2014. PMID: 25941596 Free PMC article.

10

A LAG-3-Specific Agonist Antibody for the Treatment of T Cell-Induced Autoimmune Diseases.

Angin M, Brignone C, Triebel F. Angin M, et al. Among authors: triebel f. J Immunol. 2020 Feb 15;204(4):810-818. doi: 10.4049/jimmunol.1900823. Epub 2020 Jan 6. J Immunol. 2020. PMID: 31907283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters